DexCom, Inc.
$59.06
$0.98(-1.64%)
DexCom, Inc.
DXCM
$59.06
$0.98(-1.64%)
DexCom, Inc.
DXCM
NASDAQ
$59.06
$0.98(-1.64%)
Chart
Upcoming Earnings
Next report date
Jul 29, 2026
Report period
Q3 2026
EPS Estimate
$0.60
Revenue Estimate
$1.29B
Key stats
52-Week Range$59.06
$54.11
$89.98
Market capitalization
$22.95BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
25.39Basic EPS (TTM)
$2.15Net income (TTM)
$836.30MRevenue (TTM)
$4.66BAvg. volume
4.54MBeta (1Y)
1.40Employees
10.20KMarket capitalization
$22.95BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
25.39Basic EPS (TTM)
$2.15Net income (TTM)
$836.30MRevenue (TTM)
$4.66BAvg. volume
4.54MBeta (1Y)
1.40Employees
10.20KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout DexCom, Inc.
Sector
Healthcare
Industry
Medical - Devices
CEO
Jacob Steven Leach
Website
www.dexcom.comHeadquarters
6340 Sequence Drive, San Diego, CA, 92121
IPO Date
2005-04-14
Identifiers
ISIN
US2521311074Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose...
Related Stocks
$35.86
1D:
1.4%
1Y:
118.8%
US8816242098Healthcare
Mkt Cap
$41.76B
P/E Ratio TTM
25.7
Revenue TTM
$17.26B
Beta
0.86
Earnings TTM
$1.41B
Dividend Yield TTM
0.00%
$175.30
1D:
4.2%
1Y:
10.9%
US09062X1037Healthcare
Mkt Cap
$25.72B
P/E Ratio TTM
20.1
Revenue TTM
$9.81B
Beta
0.16
Earnings TTM
$1.29B
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate